Well.. I guess OREX is making a little comeback here.. but at least they have an obesity drug currently ( even if it has a tendency to cause suicidal thoughts )..
so maybe ZFGN will catch some sympathy.. even without a drug
maybe this is the place to get in, maybe not. Any stock that goes from $45.00 to $3.27 in a year is serious cause for concern. more likely to go .45 than back to $45.00 in the next year.. Purely speaking from a Statistical perspective.
on a positive note: How much money does ZFGN have? enough to develop this 'New' drug take through trials??.. or will they need to do a capital raise?